These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2984621)

  • 1. Malignant mixed mesodermal tumor of the ovary: a report of 22 cases.
    Dictor M
    Obstet Gynecol; 1985 May; 65(5):720-4. PubMed ID: 2984621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
    Barakat RR; Rubin SC; Wong G; Saigo PE; Markman M; Hoskins WJ
    Obstet Gynecol; 1992 Oct; 80(4):660-4. PubMed ID: 1328975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.
    Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):409-12. PubMed ID: 2841630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
    Provenza C; Young RH; Prat J
    Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant mixed mesodermal tumors of the ovary: a clinicopathologic assessment of 12 cases.
    Barwick KW; LiVolsi VA
    Am J Surg Pathol; 1980 Feb; 4(1):37-42. PubMed ID: 6244746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A malignant mixed mesodermal tumor of the ovary].
    Nakata Y; Morita M; Mori Y
    Gan No Rinsho; 1990 Oct; 36(12):2210-7. PubMed ID: 2172588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ cell tumors of the ovary: a clinicopathologic study of 121 cases from Nepal.
    Sah SP; Uprety D; Rani S
    J Obstet Gynaecol Res; 2004 Aug; 30(4):303-8. PubMed ID: 15238107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
    Young RH
    Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases.
    Navani SS; Alvarado-Cabrero I; Young RH; Scully RE
    Gynecol Oncol; 1996 Dec; 63(3):371-8. PubMed ID: 8946874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
    Ordi J; Schammel DP; Rasekh L; Tavassoli FA
    Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.